08/13/2025
4:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/13/2025
4:16 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2025
8:38 PM | Ampliphi Biosciences (Subject)
Armata Pharmaceuticals, Inc. (Subject)
Innoviva, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
08/12/2025
3:36 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2025
3:16 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:05 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Birx Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
6:06 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:07 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
4:01 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
04/28/2025
4:04 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form ARS | |
03/20/2025
7:30 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
7:32 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2025
4:49 PM | Ampliphi Biosciences (Subject)
Armata Pharmaceuticals, Inc. (Subject)
Innoviva, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
03/12/2025
4:14 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
6:38 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:07 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:33 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:50 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
MarketBeat All Access